WAVE Life Sciences (WVE) Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to WAVE Life Sciences (WVE) Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

September 24, 2024 4:01 PM EDT

CAMBRIDGE, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced today that it has commenced an underwritten public offering of $175 million in aggregate of its ordinary shares, and, to certain investors that so choose in lieu of ordinary shares, pre-funded warrants to purchase ordinary shares. In connection with the offering, Wave intends to grant the underwriters a 30-day option to purchase ordinary shares in an amount up to an additional 15% of... More